BLSIF (Britannia Life Sciences) Current Accrued Expense: $0.77 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Britannia Life Sciences Current Accrued Expense?

Britannia Life Sciences BLSIF Current Accrued Expense is $0.77 Mil as of Mar. 2026. The stock has 5 warning signs investors should review.

Britannia Life Sciences's Current Accrued Expense for the quarter that ended in Mar. 2026 was $0.77 Mil.

Britannia Life Sciences's quarterly Current Accrued Expense stayed the same from Sep. 2025 ($0.00 Mil) to Dec. 2025 ($0.00 Mil) but then increased from Dec. 2025 ($0.00 Mil) to Mar. 2026 ($0.77 Mil).

Britannia Life Sciences's annual Current Accrued Expense increased from Mar. 2024 ($0.45 Mil) to Mar. 2025 ($0.87 Mil) but then declined from Mar. 2025 ($0.87 Mil) to Mar. 2026 ($0.77 Mil).

Britannia Life Sciences Current Accrued Expense Related Terms

Britannia Life Sciences Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Britannia Life Sciences's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Britannia Life Sciences Current Accrued Expense Chart

Britannia Life Sciences Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Current Accrued Expense
Get a 7-Day Free Trial 0.14 0.00 0.45 0.87 0.77

Britannia Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.87 0.00 0.00 0.00 0.77

Britannia Life Sciences Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.77 Mil mean?
Britannia Life Sciences (BLSIF) has a Current Accrued Expense of $0.77 Mil as of Mar. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Britannia Life Sciences and its competitors.
Is Britannia Life Sciences' Current Accrued Expense too high?
Britannia Life Sciences' current Current Accrued Expense is $0.77 Mil.
How does Britannia Life Sciences' Current Accrued Expense compare to VRTX and REGN?
Britannia Life Sciences' Current Accrued Expense of $0.77 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Biotechnology company?
A good Current Accrued Expense depends on the Biotechnology industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Britannia Life Sciences and its competitors. Britannia Life Sciences's current Current Accrued Expense is $0.77 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Britannia Life Sciences stock overvalued right now?
Britannia Life Sciences (BLSIF) has a current Current Accrued Expense of $0.77 Mil. The current Current Accrued Expense is $0.77 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Britannia Life Sciences (BLSIF), the current Current Accrued Expense is $0.77 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Britannia Life Sciences Business Description

Other Exchanges BLAB:Canada
Address 120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1
Britannia Life Sciences Inc provides product testing, safety assessment, and manufacturing services to the cosmetic and consumer packaged goods industries in the United Kingdom and globally.